This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial.
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience / Moscarella, Elisabetta; Varricchio, Attilio; Stabile, Eugenio; Latib, Azeem; Ielasi, Alfonso; Tespili, Maurizio; Cortese, Bernardo; Calabro', Paolo; Granata, Francesco; Panoulas, Vasileios F; Franzone, Anna; Trimarco, Bruno; Bonzani, Giulio; Esposito, Giovanni; Colombo, Antonio. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 1874-1754. - 199:(2015), p. 366-72. [10.1016/j.ijcard.2015.07.002]
Bioresorbable vascular scaffold implantation for the treatment of coronary in-stent restenosis: results from a multicenter Italian experience
STABILE, EUGENIO;CALABRO', PAOLO;GRANATA, FRANCESCO;FRANZONE, ANNA;TRIMARCO, BRUNO;ESPOSITO, GIOVANNI;
2015
Abstract
This multicenter experience sought to investigate the feasibility and safety of BVS for the treatment of ISR. From April 2012 to June 2014, a total of 315 patients (334 lesions) underwent PCI for ISR at the participating centers. Of those, 83 patients (90 lesions) received BVS. Procedural success was achieved in all patients. At a median of 7 (IQR 3-18) months follow-up, MACCE rate was 12%, TLR 7.7%, while one (1.1%) definite BVS-in-stent thrombosis was reported. The results of this multicenter experience suggest that BVS implantation for the treatment of coronary ISR is technically feasible and associated with favorable mid-term clinical results. These data could be considered hypothesis generating for a future randomized clinical trial.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S0167527315301248-main.pdf
solo utenti autorizzati
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
721.63 kB
Formato
Adobe PDF
|
721.63 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
